Skip to content

2018

 

April-Obtained more than 200 million CNY A round financing jointly participated by several institutions. Start the construction of single molecule gene sequencer and supporting reagent production line, and the application of medical device license.

 

September-The company’s R&D and production base officially settled in Luohu District, with a total work area more than 8,000 square meters, including more than 3,000 square meters of sequencer and kit GMP production lines.